More and more pharma companies at securPharm
Over 40 pharmaceutical companies already joined securPharm. To the latest participants belong: Apo-Care Pharma GmbH, Bayer Vital GmbH, Dr. August Wolff GmbH & Co. KG Arzneimittel, Janssen-Cilag GmbH, Lilly Deutschland GmbH, neuraxpharm Arzneimittel GmbH, onkovis GmbH, Orifarm GmbH, Vertriebsgesellschaft Bristol-Myers Squibb GmbH & Co. KGaA/Pfizer Pharma GmbH and intersero GmbH.
If your company also wants to connect to the German system for the authentication of prescription drugs please contact ACS PharmaProtect GmbH. ACS PharmaProtect operates the database of the pharmaceutical industry. Your contact partners are Mr. Tobias Beer (email@example.com or +49 (30) 577 037-902) and Mrs. Maria Mehnert (firstname.lastname@example.org or +49 (30) 577 037-907). The participation to ACS/securPharm is possible any time – even if you have not made the necessary technical provisions in your company yet.
Companies which conclude a contract with ACS PharmaProtect GmbH till June 30, 2016 profit from the favorable conditions of the fee model which make an early conclusion of contract financially attractive. In Germany the connection with this database is the prerequisite for the pharmaceutical companies to participate in securPharm and to implement the specifications of the FMD. Further information regarding the database system of the pharmaceutical industry are available at www.pharmaprotect.de/en.